Articles

Results 1 to 5 of 5


Senate passes drug pricing legislation

USA - August 8 2022 On August 7, 2022, the Senate passed the proposed Inflation Reduction Act of 2022, which includes a number of significant drug pricing-related…

Alice Valder Curran, Melissa K. Bianchi, Mahmud Brifkani, Ken Choe, Elizabeth (Beth) Halpern, Ashley Ifeadike, Stuart M. Langbein, Samantha D. Marshall, Kathleen A. Peterson, Beth L. Roberts, Anna Weinstein

Panelists sum up state of health care AI regulation, standards, and data challenges

USA - July 1 2022 At our recent Health Care AI Law and Policy Summit, Hogan Lovells partner Melissa Bianchi moderated a panel discussion on the state of the health care…

Melissa K. Bianchi

Panelists discuss present & future reimbursement mechanisms for AI health care products

USA - June 28 2022 At our recent Health Care AI Law and Policy Summit, Hogan Lovells partner Stuart Langbein moderated a panel discussion on AI policy and reimbursement…

Stuart M. Langbein

U.S. House passes drug pricing legislation

USA - November 19 2021 This morning, the U.S. House passed drug pricing legislation as part of the Build Back Better Act (BBBA) (specifically the Rules Committee version…

Alice Valder Curran, Melissa K. Bianchi, Ken Choe, Elizabeth (Beth) Halpern, Stuart M. Langbein, Samantha D. Marshall, Kathleen A. Peterson, Beth L. Roberts, Anna Weinstein, Ron Wisor

Ramping up the drug pricing debate: Dueling bills and paying for health care infrastructure

USA - April 26 2021 The U.S. House of Representatives is considering dueling proposals related to drug pricing under Medicaid and Medicare, including the Republican-led H…

Alice Valder Curran, Thomas Beimers, Melissa K. Bianchi, Mahmud Brifkani, Ken Choe, James M. Deal, Elizabeth (Beth) Halpern, James Huang, W. Boyd Jackson, Stuart M. Langbein, Samantha D. Marshall, Beth L. Roberts, Anna Weinstein, Ron Wisor